Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Chronic myelogenous leukemia - Treatment and monitoring
Nikolas Von Bubnoff
*
, Justus Duyster
*
Corresponding author for this work
Clinic of Hematology and Oncology
Technical University of Munich
30
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chronic myelogenous leukemia - Treatment and monitoring'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Protein Tyrosine Kinase Inhibitor
28%
Remission
14%
Alpha Interferon
14%
Busulfan
14%
Overall Survival
14%
Progression Free Survival
14%
Nilotinib
14%
Hydroxycarbamide
14%